Infectious Diseases: Leishmaniasis



Fig. 15.1
New World Leishmaniasis. Ulcerated plaque with satellite lesions on the arm of a young female. PCR identified L. panamensis



A322609_1_En_15_Fig2_HTML.jpg


Fig. 15.2
New World Leishmaniasis. Crusted, eroded plaques on the arm due to L. panamensis


A322609_1_En_15_Fig3_HTML.jpg


Fig. 15.3
New World Leishmaniasis. Furuncular nodule due to L. panamensis


MCL (espundia) results from dissemination of parasites from the skin to oropharyngeal or nasal mucosa in untreated or incompletely treated cases of New World CL. Responsible species include L. amazonensis and the L. Viannia braziliensis species complex. MCL typically occurs within several years of the onset of CL. Ulcerative plaques result in stuffiness, bleeding, and septal perforation [2].

Old World infections are transmitted by the sandfly Phlebotomus while the vector for New World infections is the sandfly Lutzomyia [1].



Management Strategy


Overall, two-thirds of CL can be cured without systemic therapy [3]. For Old World CL, systemic treatment is recommended for patients with multiple (>4) or large (>5 cm) lesions, involvement of potentially disfiguring sites (face, hands, feet, joints), or a history of immunosuppression. In the absence of these criteria, local therapy may be utilized for Old World CL. Systemic treatment options for Old World CL include pentavalent antimonials (Sbv) and oral azoles. Local therapies for Old World CL include paromomycin ointment, intralesional antimonials, thermotherapy, and cryotherapy.

Systemic treatment is warranted for New World CL in patients with multiple or large (>3 cm) lesions, involvement of potentially disfiguring sites, a history of immunosuppression, low probability of follow-up, severe lesions or concomitant mucosal disease. If none of these criteria are present, local therapy (thermotherapy, paromomycin ointment, intralesional antimonials) may be used. MCL requires systemic therapy. Systemic treatments for New World CL and MCL include Sbv, miltefosine, pentamidine, azoles, amphotericin B deoxycholate, and liposomal amphotericin B [4].


Specific Investigations




























For diagnosis

 Histopathology

 Culture

 Polymerase chain reaction (PCR)

 Tissue impression smear (touch preparation)

 Dermal scraping (thin smear)

For treatment

 Electrocardiogram (ECG)

 Laboratory: liver function test (LFT), renal function (blood urea nitrogen and creatinine), metabolic panel (blood glucose, potassium), amylase and lipase

 Blood pressure

For optimal diagnosis, three punch biopsies should be obtained. The first sample should be submitted in formalin for histopathology, the second rolled on a glass slide then fixed with methanol and stained for Giemsa for touch preparation, and the third submitted in Roswell Park Memorial Institute (RPMI) media for culture and PCR analysis. Histopathology is up to 70 % sensitive in the detection of intracellular amastigotes. Cultures are positive within 4 weeks in over 80 % of cases in which organisms are identified on histology, and in almost 30 % of cases negative on histology. Fine-needle aspirates and dermal scrapings may be used for cultures in lieu of punch biopsy. PCR offers a detection rate up to 97 % and, unlike culture and histology, provides speciation which is important for treatment [3]. The United States Centers for Disease Control and Prevention (CDC) provides RPMI media and evaluation of biopsy specimens for histology, culture, touch preparations, and PCR free of charge. Details regarding collection and submission of specimens can be accessed online at: http://​www.​cdc.​gov/​parasites/​leishmaniasis/​resources/​pdf/​cdc_​-diagnosis_​guide_​leishmaniasis_​nov.​2015.​pdf [4].

The major toxicities of systemic pentavalent antimonials (Sbv, sodium stibogluconate, and meglumin antimoniate) are cardiac arrhythmias, hepatitis, pancreatitis; minor effects include arthralgias and myalgias. The adverse effects of amphotericin B include infusion reactions, renal failure, hypokalemia, and myocarditis. Miltefosine is associated with renal and hepatic toxicity as well as gastrointestinal side effects and teratogenicity. Paromomycin is an aminoglycoside associated with hepatic transaminitis and rare ototoxicity. Pentamadine may cause hypotension, hyperglycemia or hypoglycemia, and gastrointestinal side effects. Azole antifungals can be hepatotoxic. Thus, ECG, LFT, blood urea nitrogen and creatinine, blood glucose, potassium, and amylase and lipase should be evaluated prior to and during systemic treatment for CL and MCL [5].


Table 15.1
First-line therapies for old world CL










































Medication

Dosing

Species

Evidence level

Sbv

20 mg/kg/day × 14 days (systemic)

L. major

A [6]

5 injections of 2–5 mL every 5–7 days (intralesional)

A [7]

Miltefosine

2.5 mg/kg/day × 28 days

L. major

A [6]

15 % paromomycin with or without 0.5 % gentamicin ointment

BID × 20 days

L. major

A [8]

CO2 slush

1 min to lesion, repeat monthly
 
B [9]

Cryotherapy

Weekly treatment for 1–4 weeks

L. major

B [10]

In one study, both intramuscular stibogluconate and oral miltefosine showed greater than 80 % cure rates for CL caused by L. major. Another study, however, showed only 45 % efficacy for intramuscular stibogluconate (20 mg/kg for 21 days), whereas intralesional stibogluconate (five injections of 2–5 mL every 5–7 days) was 75 % effective, and thermotherapy (radiofrequency waves applied once at 50 °C for 30 s), a second-line therapy, was 70 % effective for Old World CL. A randomized, placebo-controlled trial of paromomycin ointment (with or without gentamicin ointment) demonstrated over 80 % efficacy in the treatment of Old World CL due to L. major. A study performed in Yemen reported CO2 slush applied once or twice was over 90 % effective for the treatment of Old World CL. Finally, cryotherapy was shown to be cost-effective and cured 84 % of lesions with minimal scarring and side effects following weekly treatments for 1–4 weeks.


Table 15.2
Second-line therapies for old world CL























Medication

Dosing

Species

Evidence level

Itraconazole

4 mg/kg/day × 6 weeks
 
A [11, 12]

200 mg/day × 8 weeks

Thermotherapy (radiofrequency waves)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 13, 2017 | Posted by in Dermatology | Comments Off on Infectious Diseases: Leishmaniasis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access